A citation-based method for searching scientific literature

Lori L Isom, Kelly G Knupp. Neurotherapeutics 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.
Aleksandr Shcheglovitov, Randall T Peterson. Neurotherapeutics 2021
1
100

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.
Ingrid E Scheffer, Samuel Berkovic, Giuseppe Capovilla, Mary B Connolly, Jacqueline French, Laura Guilhoto, Edouard Hirsch, Satish Jain, Gary W Mathern, Solomon L Moshé,[...]. Epilepsia 2017
50

Electrophysiological Biomarkers in Genetic Epilepsies.
Caren Armstrong, Eric D Marsh. Neurotherapeutics 2021
1
100

Rational Small Molecule Treatment for Genetic Epilepsies.
Ethan M Goldberg. Neurotherapeutics 2021
1
100

Precision Therapy for Epilepsy Related to Brain Malformations.
Alissa M D'Gama, Annapurna Poduri. Neurotherapeutics 2021
2
50

Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
Jenna C Carpenter, Gabriele Lignani. Neurotherapeutics 2021
1
100

Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome.
Nycole A Copping, Stephanie M McTighe, Kyle D Fink, Jill L Silverman. Neurotherapeutics 2021
1
100

Possible precision medicine implications from genetic testing using combined detection of sequence and intragenic copy number variants in a large cohort with childhood epilepsy.
Rebecca Truty, Nila Patil, Raman Sankar, Joseph Sullivan, John Millichap, Gemma Carvill, Ali Entezam, Edward D Esplin, Amy Fuller, Michelle Hogue,[...]. Epilepsia Open 2019
28
50

Novel Therapeutics for Neonatal Seizures.
Julie M Ziobro, Krista Eschbach, Renée A Shellhaas. Neurotherapeutics 2021
1
100

Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury.
Chris G Dulla, Asla Pitkänen. Neurotherapeutics 2021
1
100



Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.
Elizabeth E Palmer, Katherine Howell, Ingrid E Scheffer. Neurotherapeutics 2021
2
50

Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.
Dylan C Brock, Scott Demarest, Tim A Benke. Neurotherapeutics 2021
1
100

Potentiation of anti-epileptic drugs effectiveness by pyronaridine in refractory epilepsy.
Ali Akbar Asadi-Pooya, Michael R Sperling. Med Hypotheses 2007
5
50

Therapeutic advances in Dravet syndrome: a targeted literature review.
Adam Strzelczyk, Susanne Schubert-Bast. Expert Rev Neurother 2020
14
50

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.
Lieven Lagae, Joseph Sullivan, Kelly Knupp, Linda Laux, Tilman Polster, Marina Nikanorova, Orrin Devinsky, J Helen Cross, Renzo Guerrini, Dinesh Talwar,[...]. Lancet 2019
78
50

Responsive Neurostimulation for the Treatment of Epilepsy.
Caio M Matias, Ashwini Sharan, Chengyuan Wu. Neurosurg Clin N Am 2019
12
50

A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood.
Han Yan, Eric Toyota, Melanie Anderson, Taylor J Abel, Elizabeth Donner, Suneil K Kalia, James Drake, James T Rutka, George M Ibrahim. J Neurosurg Pediatr 2018
27
50

The glucose transporter type 1 (Glut1) syndromes.
Henner Koch, Yvonne G Weber. Epilepsy Behav 2019
40
50

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Elizabeth A Thiele, Eric D Marsh, Jacqueline A French, Maria Mazurkiewicz-Beldzinska, Selim R Benbadis, Charuta Joshi, Paul D Lyons, Adam Taylor, Claire Roberts, Kenneth Sommerville. Lancet 2018
338
50

Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
Jianxiong Jiang, Yi Quan, Thota Ganesh, Wendy A Pouliot, F Edward Dudek, Raymond Dingledine. Proc Natl Acad Sci U S A 2013
112
50

Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration.
Dinesh Upadhya, Bharathi Hattiangady, Olagide W Castro, Bing Shuai, Maheedhar Kodali, Sahithi Attaluri, Adrian Bates, Yi Dong, Su-Chun Zhang, Darwin J Prockop,[...]. Proc Natl Acad Sci U S A 2019
39
50

Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study.
Wyman W Lai, Bradley S Galer, Pierre C Wong, Gail Farfel, Milka Pringsheim, Martin G Keane, Anupam Agarwal. Epilepsia 2020
9
50

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy.
Annamaria Vezzani, Silvia Balosso, Teresa Ravizza. Nat Rev Neurol 2019
174
50

A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures.
Felippe Borlot, Robert G Wither, Anfal Ali, Nicky Wu, Flavia Verocai, Danielle M Andrade. Epilepsy Res 2014
21
50


Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations.
Mark M Souweidane, Justin F Fraser, Lisa M Arkin, Dolan Sondhi, Neil R Hackett, Stephen M Kaminsky, Linda Heier, Barry E Kosofsky, Stefan Worgall, Ronald G Crystal,[...]. J Neurosurg Pediatr 2010
47
50

GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.
Tyler Mark Pierson, Hongjie Yuan, Eric D Marsh, Karin Fuentes-Fajardo, David R Adams, Thomas Markello, Gretchen Golas, Dimitre R Simeonov, Conisha Holloman, Anel Tankovic,[...]. Ann Clin Transl Neurol 2014
143
50

Non-viral vectors for gene-based therapy.
Hao Yin, Rosemary L Kanasty, Ahmed A Eltoukhy, Arturo J Vegas, J Robert Dorkin, Daniel G Anderson. Nat Rev Genet 2014
50

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
Gregory L Krauss, Pavel Klein, Christian Brandt, Sang Kun Lee, Ivan Milanov, Maja Milovanovic, Bernhard J Steinhoff, Marc Kamin. Lancet Neurol 2020
53
50

Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Orrin Devinsky, Anup D Patel, J Helen Cross, Vicente Villanueva, Elaine C Wirrell, Michael Privitera, Sam M Greenwood, Claire Roberts, Daniel Checketts, Kevan E VanLandingham,[...]. N Engl J Med 2018
325
50

Structure and mechanism of ABC transporters.
Stephan Wilkens. F1000Prime Rep 2015
268
50

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study.
Michael R Sperling, Pavel Klein, Sami Aboumatar, Michael Gelfand, Jonathan J Halford, Gregory L Krauss, William E Rosenfeld, David G Vossler, Robert Wechsler, Leona Borchert,[...]. Epilepsia 2020
26
50

Correction of a Splicing Mutation Affecting an Unverricht-Lundborg Disease Patient by Antisense Therapy.
Liliana Matos, Ana Joana Duarte, Diogo Ribeiro, João Chaves, Olga Amaral, Sandra Alves. Genes (Basel) 2018
7
50

Pharmacogenomics in epilepsy.
Simona Balestrini, Sanjay M Sisodiya. Neurosci Lett 2018
57
50

Novel therapies for epilepsy in the pipeline.
Boulenouar Mesraoua, Dirk Deleu, Dimitri M Kullmann, Ashok K Shetty, Paul Boon, Emilio Perucca, Mohamad A Mikati, Ali A Asadi-Pooya. Epilepsy Behav 2019
15
50

Personalized therapy in a GRIN1 mutated girl with intellectual disability and epilepsy.
Filomena T Papa, Maria M Mancardi, Elisa Frullanti, Chiara Fallerini, Veronica Della Chiara, Laura Zalba-Jadraque, Margherita Baldassarri, Alessandra Gamucci, Francesca Mari, Edvige Veneselli,[...]. Clin Dysmorphol 2018
3
50


n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis.
Federica Frigerio, Giulia Pasqualini, Ilaria Craparotta, Sergio Marchini, Erwin A van Vliet, Patrick Foerch, Catherine Vandenplas, Karin Leclercq, Eleonora Aronica, Luca Porcu,[...]. Brain 2018
35
50

Three decades of P-gp inhibitors: skimming through several generations and scaffolds.
A Palmeira, E Sousa, M H Vasconcelos, M M Pinto. Curr Med Chem 2012
288
50


Personalized medicine approaches in epilepsy.
L E Walker, N Mirza, V L M Yip, A G Marson, M Pirmohamed. J Intern Med 2015
32
50

Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.
David P D Woldbye, Mikael Angehagen, Casper R Gøtzsche, Heidi Elbrønd-Bek, Andreas T Sørensen, Søren H Christiansen, Mikkel V Olesen, Litsa Nikitidou, Thomas V O Hansen, Irene Kanter-Schlifke,[...]. Brain 2010
64
50

Brain inflammation as a biomarker in epilepsy.
Annamaria Vezzani, Alon Friedman. Biomark Med 2011
141
50

ILAE official report: a practical clinical definition of epilepsy.
Robert S Fisher, Carlos Acevedo, Alexis Arzimanoglou, Alicia Bogacz, J Helen Cross, Christian E Elger, Jerome Engel, Lars Forsgren, Jacqueline A French, Mike Glynn,[...]. Epilepsia 2014
50


Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus.
Xiang-Fei Meng, Lan Tan, Meng-Shan Tan, Teng Jiang, Chen-Chen Tan, Meng-Meng Li, Hui-Fu Wang, Jin-Tai Yu. J Neuroinflammation 2014
47
50

A viral strategy for targeting and manipulating interneurons across vertebrate species.
Jordane Dimidschstein, Qian Chen, Robin Tremblay, Stephanie L Rogers, Giuseppe-Antonio Saldi, Lihua Guo, Qing Xu, Runpeng Liu, Congyi Lu, Jianhua Chu,[...]. Nat Neurosci 2016
172
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.